Exploration of Targeted Anti-tumor Therapy

Exploration of Targeted Anti-tumor Therapy https://www.explorationpub.com/Journals/etat Most Recent Articles : Exploration of Targeted Anti-tumor Therapy. en-us Tue, 12 May 2026 16:32:53 GMT Exploration of Targeted Anti-tumor Therapy: a contribution to the development of targeted therapies https://www.explorationpub.com/Journals/etat/Article/10021 Not applicable. Editorial Sat, 29 Feb 2020 00:00:00 GMT Sat, 29 Feb 2020 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/10021 Targeted inhibition of mRNA translation initiation factors as a novel therapeutic strategy for mature B-cell neoplasms https://www.explorationpub.com/Journals/etat/Article/10022 Not applicable. Review Sat, 29 Feb 2020 00:00:00 GMT Sat, 29 Feb 2020 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/10022 Inhibitors of the Fanconi anaemia pathway as potential antitumour agents for ovarian cancer https://www.explorationpub.com/Journals/etat/Article/10023 Not applicable. Review Sat, 29 Feb 2020 00:00:00 GMT Sat, 29 Feb 2020 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/10023 Colorectal cancer genomic biomarkers in the clinical management of patients with metastatic colorectal carcinoma https://www.explorationpub.com/Journals/etat/Article/10024 Not applicable. Review Sat, 29 Feb 2020 00:00:00 GMT Sat, 29 Feb 2020 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/10024 Implementation of an NGS panel for clinical practice in paraffin-embedded tissue samples from locally advanced and metastatic melanoma patients https://www.explorationpub.com/Journals/etat/Article/10026 Not applicable. Original Article Wed, 01 Apr 2020 00:00:00 GMT Wed, 01 Apr 2020 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/10026 The impact of tumour pH on cancer progression: strategies for clinical intervention https://www.explorationpub.com/Journals/etat/Article/10025 Not applicable. Review Thu, 09 Apr 2020 00:00:00 GMT Thu, 09 Apr 2020 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/10025 Multiple adverse drug reactions during all-trans retinoic acid treatment for acute promyelocytic leukemia: differentiation syndrome, bradycardia, intestinal necrosis https://www.explorationpub.com/Journals/etat/Article/10027 Not applicable. Case Report Tue, 28 Apr 2020 00:00:00 GMT Tue, 28 Apr 2020 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/10027 Angiogenesis and epidermal growth factor receptor inhibitors in non-small cell lung cancer https://www.explorationpub.com/Journals/etat/Article/10028 Not applicable. Review Tue, 28 Apr 2020 00:00:00 GMT Tue, 28 Apr 2020 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/10028 Development of PROTACs to address clinical limitations associated with BTK-targeted kinase inhibitors https://www.explorationpub.com/Journals/etat/Article/10029 Not applicable. Review Mon, 29 Jun 2020 00:00:00 GMT Mon, 29 Jun 2020 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/10029 An overview of the anti-cancer actions of Tanshinones, derived from Salvia miltiorrhiza (Danshen) https://www.explorationpub.com/Journals/etat/Article/100210 Not applicable. Review Mon, 29 Jun 2020 00:00:00 GMT Mon, 29 Jun 2020 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100210 Role of liquid biopsy for thoracic cancers immunotherapy https://www.explorationpub.com/Journals/etat/Article/100212 Not applicable. Review Mon, 29 Jun 2020 00:00:00 GMT Mon, 29 Jun 2020 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100212 Integration of PARP-inhibitors in ovarian cancer therapy https://www.explorationpub.com/Journals/etat/Article/100211 Not applicable. Review Mon, 29 Jun 2020 00:00:00 GMT Mon, 29 Jun 2020 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100211 A brief overview of antitumoral actions of bruceine D https://www.explorationpub.com/Journals/etat/Article/100213 Not applicable. Review Wed, 22 Jul 2020 00:00:00 GMT Wed, 22 Jul 2020 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100213 Future directions and management of liquid biopsy in non-small cell lung cancer https://www.explorationpub.com/Journals/etat/Article/100215 Not applicable. Review Fri, 14 Aug 2020 00:00:00 GMT Fri, 14 Aug 2020 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100215 Circulating cancer stem cells: an interesting niche to explore https://www.explorationpub.com/Journals/etat/Article/100216 Not applicable. Commentary Fri, 14 Aug 2020 00:00:00 GMT Fri, 14 Aug 2020 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100216 PROTACs are effective in addressing the platelet toxicity associated with BCL-XL inhibitors https://www.explorationpub.com/Journals/etat/Article/100217 Not applicable. Review Tue, 18 Aug 2020 00:00:00 GMT Tue, 18 Aug 2020 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100217 Possible applications of salvianolic acid B against different cancers https://www.explorationpub.com/Journals/etat/Article/100214 Not applicable. Review Mon, 31 Aug 2020 00:00:00 GMT Mon, 31 Aug 2020 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100214 Diagnostic and prognostic role of liquid biopsy in non-small cell lung cancer: evaluation of circulating biomarkers https://www.explorationpub.com/Journals/etat/Article/100220 Not applicable. Review Fri, 09 Oct 2020 00:00:00 GMT Fri, 09 Oct 2020 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100220 Current strategies for the design of PROTAC linkers: a critical review https://www.explorationpub.com/Journals/etat/Article/100218 Not applicable. Review Mon, 12 Oct 2020 00:00:00 GMT Mon, 12 Oct 2020 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100218 Downregulation of 15-hydroxyprostaglandin dehydrogenase during acquired tamoxifen resistance and association with poor prognosis in ERα-positive breast cancer https://www.explorationpub.com/Journals/etat/Article/100221 Not applicable. Original Article Tue, 20 Oct 2020 00:00:00 GMT Tue, 20 Oct 2020 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100221 Pseudoprogression in lung cancer: a case report https://www.explorationpub.com/Journals/etat/Article/100222 Not applicable. Case Report Wed, 28 Oct 2020 00:00:00 GMT Wed, 28 Oct 2020 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100222 Potential of guggulsterone, a farnesoid X receptor antagonist, in the prevention and treatment of cancer https://www.explorationpub.com/Journals/etat/Article/100219 Not applicable. Review Thu, 29 Oct 2020 00:00:00 GMT Thu, 29 Oct 2020 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100219 Novel approaches for the rational design of PROTAC linkers https://www.explorationpub.com/Journals/etat/Article/100223 Not applicable. Review Fri, 30 Oct 2020 00:00:00 GMT Fri, 30 Oct 2020 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100223 Use of liquid biopsy in monitoring therapeutic resistance in EGFR oncogene addicted NSCLC https://www.explorationpub.com/Journals/etat/Article/100224 Not applicable. Review Tue, 24 Nov 2020 00:00:00 GMT Tue, 24 Nov 2020 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100224 Targeting transcription factors in cancer drug discovery https://www.explorationpub.com/Journals/etat/Article/100225 Not applicable. Review Fri, 04 Dec 2020 00:00:00 GMT Fri, 04 Dec 2020 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100225 An overview of the potential anticancer properties of cardamonin https://www.explorationpub.com/Journals/etat/Article/100226 Not applicable. Review Mon, 21 Dec 2020 00:00:00 GMT Mon, 21 Dec 2020 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100226 Is hyperprogressive disease a specific phenomenom of immunotherapy? https://www.explorationpub.com/Journals/etat/Article/100227 Not applicable. Letter to the Editor Tue, 29 Dec 2020 00:00:00 GMT Tue, 29 Dec 2020 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100227 Circulating biomarkers in malignant pleural mesothelioma https://www.explorationpub.com/Journals/etat/Article/100228 Not applicable. Review Tue, 29 Dec 2020 00:00:00 GMT Tue, 29 Dec 2020 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100228 An overview of immune checkpoint inhibitors in breast cancer https://www.explorationpub.com/Journals/etat/Article/100229 Not applicable. Review Tue, 29 Dec 2020 00:00:00 GMT Tue, 29 Dec 2020 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100229 Old but gold: the role of drug combinations in improving response to immune check-point inhibitors in thoracic malignancies beyond NSCLC https://www.explorationpub.com/Journals/etat/Article/100230 Not applicable. Review Fri, 29 Jan 2021 00:00:00 GMT Fri, 29 Jan 2021 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100230 Emerging role of pioneer transcription factors in targeted ERα positive breast cancer https://www.explorationpub.com/Journals/etat/Article/100231 Not applicable. Review Wed, 10 Feb 2021 00:00:00 GMT Wed, 10 Feb 2021 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100231 Immunotherapy in gynecological cancers https://www.explorationpub.com/Journals/etat/Article/100233 Not applicable. Review Fri, 19 Feb 2021 00:00:00 GMT Fri, 19 Feb 2021 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100233 Non-invasive detection of epithelial mesenchymal transition phenotype and metastatic dissemination of lung cancer by liquid biopsy https://www.explorationpub.com/Journals/etat/Article/100232 Not applicable. Review Fri, 19 Feb 2021 00:00:00 GMT Fri, 19 Feb 2021 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100232 Multi-omics tumor profiling technologies to develop precision medicine in multiple myeloma https://www.explorationpub.com/Journals/etat/Article/100234 Not applicable. Review Sun, 28 Feb 2021 00:00:00 GMT Sun, 28 Feb 2021 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100234 Aptamers and antibodies: rivals or allies in cancer targeted therapy? https://www.explorationpub.com/Journals/etat/Article/100235 Not applicable. Review Sun, 28 Feb 2021 00:00:00 GMT Sun, 28 Feb 2021 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100235 Potential benefit of β-glucans as adjuvant therapy in immuno-oncology: a review https://www.explorationpub.com/Journals/etat/Article/100236 Not applicable. Review Tue, 09 Mar 2021 00:00:00 GMT Tue, 09 Mar 2021 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100236 Targeting HER2 in breast cancer: new drugs and paradigms on the horizon https://www.explorationpub.com/Journals/etat/Article/100237 Not applicable. Review Tue, 23 Mar 2021 00:00:00 GMT Tue, 23 Mar 2021 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100237 Liquid biopsy in NSCLC: a new challenge in radiation therapy https://www.explorationpub.com/Journals/etat/Article/100238 Not applicable. Review Tue, 13 Apr 2021 00:00:00 GMT Tue, 13 Apr 2021 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100238 Gastrointestinal disorders as immune-related adverse events https://www.explorationpub.com/Journals/etat/Article/100239 Not applicable. Review Tue, 13 Apr 2021 00:00:00 GMT Tue, 13 Apr 2021 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100239 Nuclear factor erythroid 2-related factor 2 modulates HER4 receptor in ovarian cancer cells to influence their sensitivity to tyrosine kinase inhibitors https://www.explorationpub.com/Journals/etat/Article/100240 Not applicable. Original Article Tue, 20 Apr 2021 00:00:00 GMT Tue, 20 Apr 2021 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100240 Analysis of DNA from liquid biopsy: new genetic biomarkers for cancer immunotherapy? https://www.explorationpub.com/Journals/etat/Article/100241 Not applicable. Editorial Tue, 20 Apr 2021 00:00:00 GMT Tue, 20 Apr 2021 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100241 Understanding doxorubicin associated calcium remodeling during triple-negative breast cancer treatment: an in silico study https://www.explorationpub.com/Journals/etat/Article/100242 Not applicable. Original Article Fri, 30 Apr 2021 00:00:00 GMT Fri, 30 Apr 2021 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100242 Tumor burden as possible biomarker of outcome in advanced NSCLC patients treated with immunotherapy: a single center, retrospective, real-world analysis https://www.explorationpub.com/Journals/etat/Article/100243 Not applicable. Original Article Fri, 28 May 2021 00:00:00 GMT Fri, 28 May 2021 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100243 Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type https://www.explorationpub.com/Journals/etat/Article/100244 Not applicable. Case Report Fri, 28 May 2021 00:00:00 GMT Fri, 28 May 2021 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100244 Overview of Ca2+ signaling in lung cancer progression and metastatic lung cancer with bone metastasis https://www.explorationpub.com/Journals/etat/Article/100245 Not applicable. Review Fri, 28 May 2021 00:00:00 GMT Fri, 28 May 2021 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100245 Advances in the study of cancer metastasis and calcium signaling as potential therapeutic targets https://www.explorationpub.com/Journals/etat/Article/100246 Not applicable. Review Mon, 21 Jun 2021 00:00:00 GMT Mon, 21 Jun 2021 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100246 Targeting cytoskeletal phosphorylation in cancer https://www.explorationpub.com/Journals/etat/Article/100247 Not applicable. Review Tue, 29 Jun 2021 00:00:00 GMT Tue, 29 Jun 2021 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100247 The effect of iron on the expression levels of calcium related gene in cisplatin resistant epithelial ovarian cancer cells https://www.explorationpub.com/Journals/etat/Article/100248 Not applicable. Original Article Wed, 11 Aug 2021 00:00:00 GMT Wed, 11 Aug 2021 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100248 The promising potential of piperlongumine as an emerging therapeutics for cancer https://www.explorationpub.com/Journals/etat/Article/100249 Not applicable. Review Tue, 24 Aug 2021 00:00:00 GMT Tue, 24 Aug 2021 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100249 The evolving role and utility of off-label drug use in multiple myeloma https://www.explorationpub.com/Journals/etat/Article/100250 Not applicable. Review Tue, 24 Aug 2021 00:00:00 GMT Tue, 24 Aug 2021 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100250 Does the gut microbiome environment influence response to systemic breast cancer treatment? https://www.explorationpub.com/Journals/etat/Article/100251 Not applicable. Review Tue, 24 Aug 2021 00:00:00 GMT Tue, 24 Aug 2021 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100251 Role of estrogen receptor coregulators in endocrine resistant breast cancer https://www.explorationpub.com/Journals/etat/Article/100252 Not applicable. Review Tue, 31 Aug 2021 00:00:00 GMT Tue, 31 Aug 2021 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100252 A novel strategy for treating cancer: understanding the role of Ca2+ signaling from nociceptive TRP channels in regulating cancer progression https://www.explorationpub.com/Journals/etat/Article/100253 Not applicable. Review Sun, 26 Sep 2021 00:00:00 GMT Sun, 26 Sep 2021 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100253 Current options and future directions of systemic therapy for advanced biliary tract cancer https://www.explorationpub.com/Journals/etat/Article/100254 Not applicable. Review Sat, 09 Oct 2021 00:00:00 GMT Sat, 09 Oct 2021 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100254 Targeting protein kinase CK2 in the treatment of cholangiocarcinoma https://www.explorationpub.com/Journals/etat/Article/100255 Not applicable. Review Sat, 09 Oct 2021 00:00:00 GMT Sat, 09 Oct 2021 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100255 A review of molecularly targeted therapy in biliary tract carcinoma: what is the next step? https://www.explorationpub.com/Journals/etat/Article/100256 Not applicable. Review Mon, 01 Nov 2021 00:00:00 GMT Mon, 01 Nov 2021 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100256 Targeted therapy of multiple myeloma https://www.explorationpub.com/Journals/etat/Article/100257 Not applicable. Review Mon, 01 Nov 2021 00:00:00 GMT Mon, 01 Nov 2021 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100257 Performing oncological procedures during COVID-19 outbreak: a picture from an Italian cancer center https://www.explorationpub.com/Journals/etat/Article/100258 Not applicable. Original Article Mon, 01 Nov 2021 00:00:00 GMT Mon, 01 Nov 2021 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100258 Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer https://www.explorationpub.com/Journals/etat/Article/100259 Not applicable. Review Mon, 01 Nov 2021 00:00:00 GMT Mon, 01 Nov 2021 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100259 Proteolysis-targeting chimeras and their implications in breast cancer https://www.explorationpub.com/Journals/etat/Article/100260 Not applicable. Review Wed, 17 Nov 2021 00:00:00 GMT Wed, 17 Nov 2021 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100260 The clinical advances of proteolysis targeting chimeras in oncology https://www.explorationpub.com/Journals/etat/Article/100261 Not applicable. Review Thu, 02 Dec 2021 00:00:00 GMT Thu, 02 Dec 2021 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100261 Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies https://www.explorationpub.com/Journals/etat/Article/100262 Not applicable. Review Tue, 07 Dec 2021 00:00:00 GMT Tue, 07 Dec 2021 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100262 Alterations in the Ca2+ toolkit in oesophageal adenocarcinoma https://www.explorationpub.com/Journals/etat/Article/100263 Not applicable. Original Article Tue, 14 Dec 2021 00:00:00 GMT Tue, 14 Dec 2021 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100263 Physical characteristics comparison between maytansinoid-based and auristatin-based antibody-drug conjugates https://www.explorationpub.com/Journals/etat/Article/100264 Not applicable. Original Article Wed, 22 Dec 2021 00:00:00 GMT Wed, 22 Dec 2021 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100264 Interface between obesity with dysfunctional metabolism and inflammation, and the triple-negative breast cancer in African American women https://www.explorationpub.com/Journals/etat/Article/100266 Not applicable. Review Fri, 31 Dec 2021 00:00:00 GMT Fri, 31 Dec 2021 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100266 The bromodomain and extra-terminal domain degrader MZ1 exhibits preclinical anti-tumoral activity in diffuse large B-cell lymphoma of the activated B cell-like type https://www.explorationpub.com/Journals/etat/Article/100265 Not applicable. Original Article Fri, 31 Dec 2021 00:00:00 GMT Fri, 31 Dec 2021 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100265 Antibody-drug conjugate therapies in multiple myeloma—what’s next on the horizon? https://www.explorationpub.com/Journals/etat/Article/100267 Not applicable. Review Fri, 14 Jan 2022 00:00:00 GMT Fri, 14 Jan 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100267 Bcl-2-like protein-10 increases aggressive features of melanoma cells https://www.explorationpub.com/Journals/etat/Article/100268 Not applicable. Original Article Sun, 30 Jan 2022 00:00:00 GMT Sun, 30 Jan 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100268 New antibody-drug conjugates (ADCs) in breast cancer—an overview of ADCs recently approved and in later stages of development https://www.explorationpub.com/Journals/etat/Article/100269 Not applicable. Review Fri, 25 Feb 2022 00:00:00 GMT Fri, 25 Feb 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100269 B-cell receptor dependent phagocytosis and presentation of particulate antigen by chronic lymphocytic leukemia cells https://www.explorationpub.com/Journals/etat/Article/100270 Not applicable. Original Article Fri, 25 Feb 2022 00:00:00 GMT Fri, 25 Feb 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100270 Engineered phosphorus dendrimers as powerful non-viral nanoplatforms for gene delivery: a great hope for the future of cancer therapeutics https://www.explorationpub.com/Journals/etat/Article/100271 Not applicable. Review Fri, 25 Feb 2022 00:00:00 GMT Fri, 25 Feb 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100271 Targeting the two-pore channel 2 in cancer progression and metastasis https://www.explorationpub.com/Journals/etat/Article/100272 Not applicable. Review Mon, 28 Feb 2022 00:00:00 GMT Mon, 28 Feb 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100272 Liver venous deprivation for resection of advanced hilar cholangiocarcinoma—a case report and review of the literature https://www.explorationpub.com/Journals/etat/Article/100273 Not applicable. Case Report Mon, 28 Feb 2022 00:00:00 GMT Mon, 28 Feb 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100273 Collateral-resistance to estrogen and HER-activated growth is associated with modified AKT, ERα, and cell-cycle signaling in a breast cancer model https://www.explorationpub.com/Journals/etat/Article/100274 Not applicable. Original Article Mon, 28 Feb 2022 00:00:00 GMT Mon, 28 Feb 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100274 Polyester materials for mRNA delivery https://www.explorationpub.com/Journals/etat/Article/100275 Not applicable. Review Fri, 11 Mar 2022 00:00:00 GMT Fri, 11 Mar 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100275 Yeast as a tool to decipher the molecular mechanisms underlying the functions of Bcl-2 family https://www.explorationpub.com/Journals/etat/Article/100276 Not applicable. Review Sat, 02 Apr 2022 00:00:00 GMT Sat, 02 Apr 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100276 Advancing antibody-drug conjugates in gynecological malignancies: myth or reality? https://www.explorationpub.com/Journals/etat/Article/100277 Not applicable. Review Tue, 19 Apr 2022 00:00:00 GMT Tue, 19 Apr 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100277 Role of PI3K/Akt/mTOR pathway in mediating endocrine resistance: concept to clinic https://www.explorationpub.com/Journals/etat/Article/100278 Not applicable. Review Sun, 24 Apr 2022 00:00:00 GMT Sun, 24 Apr 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100278 Genomic alterations in cholangiocarcinoma: clinical significance and relevance to therapy https://www.explorationpub.com/Journals/etat/Article/100279 Not applicable. Review Tue, 26 Apr 2022 00:00:00 GMT Tue, 26 Apr 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100279 The importance of targeting signalling mechanisms of the SLC39A family of zinc transporters to inhibit endocrine resistant breast cancer https://www.explorationpub.com/Journals/etat/Article/100280 Not applicable. Original Article Tue, 26 Apr 2022 00:00:00 GMT Tue, 26 Apr 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100280 Endocrine resistant breast cancer: brain metastasis https://www.explorationpub.com/Journals/etat/Article/100281 Not applicable. Perspective Wed, 27 Apr 2022 00:00:00 GMT Wed, 27 Apr 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100281 Antibody-drug conjugates: beyond current approvals and potential future strategies https://www.explorationpub.com/Journals/etat/Article/100282 Not applicable. Review Thu, 28 Apr 2022 00:00:00 GMT Thu, 28 Apr 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100282 Myeloid cell leukemia-1: a formidable barrier to anticancer therapeutics and the quest of targeting it https://www.explorationpub.com/Journals/etat/Article/100283 Not applicable. Review Tue, 24 May 2022 00:00:00 GMT Tue, 24 May 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100283 In vitro breast cancer models for studying mechanisms of resistance to endocrine therapy https://www.explorationpub.com/Journals/etat/Article/100284 Not applicable. Review Thu, 02 Jun 2022 00:00:00 GMT Thu, 02 Jun 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100284 Management of lung cancer patients during COVID-19 pandemic: dos, don’ts and don’t knows https://www.explorationpub.com/Journals/etat/Article/100285 Not applicable. Systematic Review Fri, 10 Jun 2022 00:00:00 GMT Fri, 10 Jun 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100285 Exploring new pathways in endocrine-resistant breast cancer https://www.explorationpub.com/Journals/etat/Article/100286 Not applicable. Review Mon, 20 Jun 2022 00:00:00 GMT Mon, 20 Jun 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100286 Liquid biopsy in biliary tract cancer from blood and bile samples: current knowledge and future perspectives https://www.explorationpub.com/Journals/etat/Article/100287 Not applicable. Review Wed, 22 Jun 2022 00:00:00 GMT Wed, 22 Jun 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100287 Allosteric cross-talk between the hydrophobic cleft and the BH4 domain of Bcl-2 in control of inositol 1,4,5-trisphosphate receptor activity https://www.explorationpub.com/Journals/etat/Article/100288 Not applicable. Original Article Wed, 29 Jun 2022 00:00:00 GMT Wed, 29 Jun 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100288 Advanced metastatic pancreatic neuroendocrine tumor treated successfully with peptide receptor radionuclide therapy: a case report https://www.explorationpub.com/Journals/etat/Article/100289 Not applicable. Case Report Wed, 29 Jun 2022 00:00:00 GMT Wed, 29 Jun 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100289 Combination of thermal ablation by focused ultrasound, pFAR4-IL-12 transfection and lipidic adjuvant provide a distal immune response https://www.explorationpub.com/Journals/etat/Article/100290 Not applicable. Original Article Fri, 01 Jul 2022 00:00:00 GMT Fri, 01 Jul 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100290 Consequences of the impact of COVID-19 pandemic on breast cancer at a single Italian institution https://www.explorationpub.com/Journals/etat/Article/100291 Not applicable. Original Article Fri, 29 Jul 2022 00:00:00 GMT Fri, 29 Jul 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100291 Anticancer action of plant products: changing stereotyped attitudes https://www.explorationpub.com/Journals/etat/Article/100292 Not applicable. Perspective Tue, 16 Aug 2022 00:00:00 GMT Tue, 16 Aug 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100292 Applications and challenges of biomaterial mediated mRNA delivery https://www.explorationpub.com/Journals/etat/Article/100293 Not applicable. Review Wed, 31 Aug 2022 00:00:00 GMT Wed, 31 Aug 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100293 Roles of calcium signaling in cancer metastasis to bone https://www.explorationpub.com/Journals/etat/Article/100294 Not applicable. Review Wed, 31 Aug 2022 00:00:00 GMT Wed, 31 Aug 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100294 A personalized molecular approach in multiple myeloma: the possible use of RAF/RAS/MEK/ERK and BCL-2 inhibitors https://www.explorationpub.com/Journals/etat/Article/100295 Not applicable. Review Wed, 31 Aug 2022 00:00:00 GMT Wed, 31 Aug 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100295 Endocrine therapy resistance: what we know and future directions https://www.explorationpub.com/Journals/etat/Article/100296 Not applicable. Review Wed, 31 Aug 2022 00:00:00 GMT Wed, 31 Aug 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100296 Myeloid-derived suppressor cells in colorectal cancer: prognostic biomarkers and therapeutic targets https://www.explorationpub.com/Journals/etat/Article/100297 Not applicable. Review Wed, 31 Aug 2022 00:00:00 GMT Wed, 31 Aug 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100297 miRNA therapeutics in precision oncology: a natural premium to nurture https://www.explorationpub.com/Journals/etat/Article/100298 Not applicable. Review Thu, 01 Sep 2022 00:00:00 GMT Thu, 01 Sep 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100298 Clinical applications of liquid biopsy in HPV-negative and HPV-positive head and neck squamous cell carcinoma: advances and challenges https://www.explorationpub.com/Journals/etat/Article/100299 Not applicable. Review Thu, 01 Sep 2022 00:00:00 GMT Thu, 01 Sep 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/100299 N6-methyladenosine-related microRNAs risk model trumps the isocitrate dehydrogenase mutation status as a predictive biomarker for the prognosis and immunotherapy in lower grade gliomas https://www.explorationpub.com/Journals/etat/Article/1002100 Not applicable. Original Article Fri, 30 Sep 2022 00:00:00 GMT Fri, 30 Sep 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002100 A xCT role in tumour-associated ferroptosis shed light on novel therapeutic options https://www.explorationpub.com/Journals/etat/Article/1002101 Not applicable. Commentary Tue, 25 Oct 2022 00:00:00 GMT Tue, 25 Oct 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002101 Targeted RNA-sequencing analysis for fusion transcripts detection in tumor diagnostics: assessment of bioinformatic tools reliability in FFPE samples https://www.explorationpub.com/Journals/etat/Article/1002102 Not applicable. Original Article Thu, 27 Oct 2022 00:00:00 GMT Thu, 27 Oct 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002102 Modulation of the antitumor immune response by cancer-associated fibroblasts: mechanisms and targeting strategies to hamper their immunosuppressive functions https://www.explorationpub.com/Journals/etat/Article/1002103 Not applicable. Review Thu, 27 Oct 2022 00:00:00 GMT Thu, 27 Oct 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002103 Clinical utility of liquid biopsy-based companion diagnostics in the non-small-cell lung cancer treatment https://www.explorationpub.com/Journals/etat/Article/1002104 Not applicable. Review Mon, 31 Oct 2022 00:00:00 GMT Mon, 31 Oct 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002104 Potential role of resveratrol and its nano-formulation as anti-cancer agent https://www.explorationpub.com/Journals/etat/Article/1002105 Not applicable. Review Mon, 31 Oct 2022 00:00:00 GMT Mon, 31 Oct 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002105 Steroid utility, immunotherapy, and brain tumor management: an update on conflicting therapies https://www.explorationpub.com/Journals/etat/Article/1002106 Not applicable. Review Mon, 31 Oct 2022 00:00:00 GMT Mon, 31 Oct 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002106 Perspectives of traditional Chinese medicine to patch up immune checkpoint blockers https://www.explorationpub.com/Journals/etat/Article/1002107 Not applicable. Review Mon, 31 Oct 2022 00:00:00 GMT Mon, 31 Oct 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002107 The tumor innate immune microenvironment in prostate cancer: an overview of soluble factors and cellular effectors https://www.explorationpub.com/Journals/etat/Article/1002108 Not applicable. Review Mon, 31 Oct 2022 00:00:00 GMT Mon, 31 Oct 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002108 Onosma L. as a source of anticancer agents: phytochemistry to mechanistic insight https://www.explorationpub.com/Journals/etat/Article/1002109 Not applicable. Review Tue, 01 Nov 2022 00:00:00 GMT Tue, 01 Nov 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002109 Diffusion-weighted imaging and apparent diffusion coefficient mapping of head and neck lymph node metastasis: a systematic review https://www.explorationpub.com/Journals/etat/Article/1002110 Not applicable. Systematic Review Tue, 13 Dec 2022 00:00:00 GMT Tue, 13 Dec 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002110 Mutant and non-mutant neoantigen-based cancer vaccines: recent advances and future promises https://www.explorationpub.com/Journals/etat/Article/1002111 Not applicable. Review Thu, 22 Dec 2022 00:00:00 GMT Thu, 22 Dec 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002111 Magnetite nanoparticles: an emerging adjunctive tool for the improvement of cancer immunotherapy https://www.explorationpub.com/Journals/etat/Article/1002220 Not applicable. Review Wed, 24 Apr 2024 00:00:00 GMT Wed, 24 Apr 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002220 Antibody-drug conjugates for lymphoma patients: preclinical and clinical evidences https://www.explorationpub.com/Journals/etat/Article/1002112 Not applicable. Review Tue, 27 Dec 2022 00:00:00 GMT Tue, 27 Dec 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002112 Artificial intelligence in breast cancer imaging: risk stratification, lesion detection and classification, treatment planning and prognosis—a narrative review https://www.explorationpub.com/Journals/etat/Article/1002113 Not applicable. Review Tue, 27 Dec 2022 00:00:00 GMT Tue, 27 Dec 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002113 Encouraging probiotics for the prevention and treatment of immune-related adverse events in novel immunotherapies against malignant glioma https://www.explorationpub.com/Journals/etat/Article/1002114 Not applicable. Perspective Tue, 27 Dec 2022 00:00:00 GMT Tue, 27 Dec 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002114 Dendritic cell-targeting chemokines inhibit colorectal cancer progression https://www.explorationpub.com/Journals/etat/Article/1002115 Not applicable. Original Article Tue, 27 Dec 2022 00:00:00 GMT Tue, 27 Dec 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002115 De novo cholesterol biosynthesis: an additional therapeutic target for the treatment of postmenopausal breast cancer with excessive adipose tissue https://www.explorationpub.com/Journals/etat/Article/1002116 Not applicable. Commentary Wed, 28 Dec 2022 00:00:00 GMT Wed, 28 Dec 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002116 Evaluating immune response in vitro in a relevant microenvironment: a high-throughput microfluidic model for clinical screening https://www.explorationpub.com/Journals/etat/Article/1002117 Not applicable. Original Article Thu, 29 Dec 2022 00:00:00 GMT Thu, 29 Dec 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002117 New phase therapeutic pursuits for targeted drug delivery in glioblastoma multiforme https://www.explorationpub.com/Journals/etat/Article/1002118 Not applicable. Review Fri, 30 Dec 2022 00:00:00 GMT Fri, 30 Dec 2022 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002118 Artificial intelligence fusion for predicting survival of rectal cancer patients using immunohistochemical expression of Ras homolog family member B in biopsy https://www.explorationpub.com/Journals/etat/Article/1002119 Not applicable. Original Article Tue, 07 Feb 2023 00:00:00 GMT Tue, 07 Feb 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002119 A primer on cancer-associated fibroblast mechanics and immunosuppressive ability https://www.explorationpub.com/Journals/etat/Article/1002120 Not applicable. Perspective Tue, 21 Feb 2023 00:00:00 GMT Tue, 21 Feb 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002120 Liquid biopsy and glioblastoma https://www.explorationpub.com/Journals/etat/Article/1002121 Not applicable. Review Sat, 25 Feb 2023 00:00:00 GMT Sat, 25 Feb 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002121 Enhancement of reactive oxygen species production in triple negative breast cancer cells treated with electric pulses and resveratrol https://www.explorationpub.com/Journals/etat/Article/1002122 Not applicable. Original Article Tue, 28 Feb 2023 00:00:00 GMT Tue, 28 Feb 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002122 Crude extract of Ficus deltoidea Jack (FD) as a natural biological therapy https://www.explorationpub.com/Journals/etat/Article/1002123 Not applicable. Systematic Review Tue, 28 Feb 2023 00:00:00 GMT Tue, 28 Feb 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002123 Macrophages as potential targets in gene therapy for cancer treatment https://www.explorationpub.com/Journals/etat/Article/1002124 Not applicable. Review Tue, 28 Feb 2023 00:00:00 GMT Tue, 28 Feb 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002124 Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer https://www.explorationpub.com/Journals/etat/Article/1002125 Not applicable. Review Wed, 01 Mar 2023 00:00:00 GMT Wed, 01 Mar 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002125 Research progress in molecular pathology markers in medulloblastoma https://www.explorationpub.com/Journals/etat/Article/1002126 Not applicable. Review Wed, 01 Mar 2023 00:00:00 GMT Wed, 01 Mar 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002126 Artificial intelligence applications in pediatric oncology diagnosis https://www.explorationpub.com/Journals/etat/Article/1002127 Not applicable. Review Wed, 01 Mar 2023 00:00:00 GMT Wed, 01 Mar 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002127 Cancer resistance via the downregulation of the tumor suppressors RKIP and PTEN expressions: therapeutic implications https://www.explorationpub.com/Journals/etat/Article/1002128 Not applicable. Review Fri, 21 Apr 2023 00:00:00 GMT Fri, 21 Apr 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002128 Clinicopathological relevance of stem cell marker growth and differentiation factor 3 in esophageal squamous cell carcinoma https://www.explorationpub.com/Journals/etat/Article/1002130 Not applicable. Letter to the Editor Mon, 24 Apr 2023 00:00:00 GMT Mon, 24 Apr 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002130 Ginnalin A and hamamelitannin: the unique gallotannins with promising anti-carcinogenic potential https://www.explorationpub.com/Journals/etat/Article/1002129 Not applicable. Review Fri, 21 Apr 2023 00:00:00 GMT Fri, 21 Apr 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002129 A potent bioactive fraction against colon cancer from Plectranthus vettiveroides https://www.explorationpub.com/Journals/etat/Article/1002131 Not applicable. Original Article Tue, 25 Apr 2023 00:00:00 GMT Tue, 25 Apr 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002131 Cystic presentation of primary hepatic neuroendocrine tumour: a case report with a brief review of literature https://www.explorationpub.com/Journals/etat/Article/1002133 Not applicable. Case Report Wed, 26 Apr 2023 00:00:00 GMT Wed, 26 Apr 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002133 Gut microbiota, an emergent target to shape the efficiency of cancer therapy https://www.explorationpub.com/Journals/etat/Article/1002132 Not applicable. Review Wed, 26 Apr 2023 00:00:00 GMT Wed, 26 Apr 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002132 Development and validation of an infrared-artificial intelligence software for breast cancer detection https://www.explorationpub.com/Journals/etat/Article/1002135 Not applicable. Original Article Thu, 27 Apr 2023 00:00:00 GMT Thu, 27 Apr 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002135 Anticancer of genus Syzygium: a systematic review https://www.explorationpub.com/Journals/etat/Article/1002134 Not applicable. Systematic Review Thu, 27 Apr 2023 00:00:00 GMT Thu, 27 Apr 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002134 Next-generation cancer vaccines: targeting cryptic and non-canonical antigens for precision immunotherapy https://www.explorationpub.com/Journals/etat/Article/1002338 Not applicable. Review Thu, 25 Sep 2025 00:00:00 GMT Thu, 25 Sep 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002338 Complete response to third-line treatment with trifluridine/tipiracil (TAS-102) in stage IV colon adenocarcinoma https://www.explorationpub.com/Journals/etat/Article/1002136 Not applicable. Case Report Thu, 27 Apr 2023 00:00:00 GMT Thu, 27 Apr 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002136 Transforming growth factor-β signaling: from tumor microenvironment to anticancer therapy https://www.explorationpub.com/Journals/etat/Article/1002137 Not applicable. Review Fri, 28 Apr 2023 00:00:00 GMT Fri, 28 Apr 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002137 Role of artificial intelligence in oncologic emergencies: a narrative review https://www.explorationpub.com/Journals/etat/Article/1002138 Not applicable. Review Fri, 28 Apr 2023 00:00:00 GMT Fri, 28 Apr 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002138 Small cell lung cancer: circulating tumor cell lines and expression of mediators of angiogenesis and coagulation https://www.explorationpub.com/Journals/etat/Article/1002139 Not applicable. Original Article Fri, 28 Apr 2023 00:00:00 GMT Fri, 28 Apr 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002139 Novel therapeutic strategies targeting myeloid-derived suppressor cell immunosuppressive mechanisms for cancer treatment https://www.explorationpub.com/Journals/etat/Article/1002212 Not applicable. Review Wed, 28 Feb 2024 00:00:00 GMT Wed, 28 Feb 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002212 Capitalizing glycomic changes for improved biomarker-based cancer diagnostics https://www.explorationpub.com/Journals/etat/Article/1002140 Not applicable. Review Thu, 29 Jun 2023 00:00:00 GMT Thu, 29 Jun 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002140 Real world outcomes in patients with neuroendocrine tumor receiving peptide receptor radionucleotide therapy https://www.explorationpub.com/Journals/etat/Article/1002141 Not applicable. Original Article Thu, 29 Jun 2023 00:00:00 GMT Thu, 29 Jun 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002141 Artificial intelligence and radiomics in magnetic resonance imaging of rectal cancer: a review https://www.explorationpub.com/Journals/etat/Article/1002142 Not applicable. Review Fri, 30 Jun 2023 00:00:00 GMT Fri, 30 Jun 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002142 Liquid biopsy: an examination of platelet RNA obtained from head and neck squamous cell carcinoma patients for predictive molecular tumor markers https://www.explorationpub.com/Journals/etat/Article/1002143 Not applicable. Original Article Fri, 30 Jun 2023 00:00:00 GMT Fri, 30 Jun 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002143 Continuous enzyme activity assay for high-throughput classification of histone deacetylase 8 inhibitors https://www.explorationpub.com/Journals/etat/Article/1002144 Not applicable. Original Article Fri, 30 Jun 2023 00:00:00 GMT Fri, 30 Jun 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002144 Potential tactics with vitamin D and certain phytochemicals for enhancing the effectiveness of immune-checkpoint blockade therapies https://www.explorationpub.com/Journals/etat/Article/1002145 Not applicable. Perspective Fri, 30 Jun 2023 00:00:00 GMT Fri, 30 Jun 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002145 Type 1 and type 2 cytokine-mediated immune orchestration in the tumour microenvironment and their therapeutic potential https://www.explorationpub.com/Journals/etat/Article/1002146 Not applicable. Review Sat, 01 Jul 2023 00:00:00 GMT Sat, 01 Jul 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002146 Spontaneous regression of a metastatic carcinoma transmitted by a kidney graft https://www.explorationpub.com/Journals/etat/Article/1002148 Not applicable. Case Report Sat, 01 Jul 2023 00:00:00 GMT Sat, 01 Jul 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002148 Increasing differential diagnosis between lipoma and liposarcoma through radiomics: a narrative review https://www.explorationpub.com/Journals/etat/Article/1002147 Not applicable. Review Sat, 01 Jul 2023 00:00:00 GMT Sat, 01 Jul 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002147 Glucose metabolism reprogramming promotes immune escape of hepatocellular carcinoma cells https://www.explorationpub.com/Journals/etat/Article/1002149 Not applicable. Review Sat, 01 Jul 2023 00:00:00 GMT Sat, 01 Jul 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002149 An introductory review of post-resection chemotherapeutics for primary brain tumors https://www.explorationpub.com/Journals/etat/Article/1002150 Not applicable. Review Sat, 01 Jul 2023 00:00:00 GMT Sat, 01 Jul 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002150 Current role of machine learning and radiogenomics in precision neuro-oncology https://www.explorationpub.com/Journals/etat/Article/1002151 Not applicable. Review Wed, 19 Jul 2023 00:00:00 GMT Wed, 19 Jul 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002151 Potential tactics with certain gut microbiota for the treatment of unresectable hepatocellular carcinoma https://www.explorationpub.com/Journals/etat/Article/1002152 Not applicable. Perspective Thu, 24 Aug 2023 00:00:00 GMT Thu, 24 Aug 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002152 Emerging role of quantitative imaging (radiomics) and artificial intelligence in precision oncology https://www.explorationpub.com/Journals/etat/Article/1002153 Not applicable. Review Thu, 24 Aug 2023 00:00:00 GMT Thu, 24 Aug 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002153 B-cell lymphoma 2 family members and sarcomas: a promising target in a heterogeneous disease https://www.explorationpub.com/Journals/etat/Article/1002154 Not applicable. Review Thu, 24 Aug 2023 00:00:00 GMT Thu, 24 Aug 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002154 Aspirin and the metabolic hallmark of cancer: novel therapeutic opportunities for colorectal cancer https://www.explorationpub.com/Journals/etat/Article/1002155 Not applicable. Review Tue, 29 Aug 2023 00:00:00 GMT Tue, 29 Aug 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002155 Nuclear epidermal growth factor receptor as a therapeutic target https://www.explorationpub.com/Journals/etat/Article/1002156 Not applicable. Review Wed, 30 Aug 2023 00:00:00 GMT Wed, 30 Aug 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002156 Nanomedicine strategies to counteract cancer stemness and chemoresistance https://www.explorationpub.com/Journals/etat/Article/1002157 Not applicable. Review Thu, 31 Aug 2023 00:00:00 GMT Thu, 31 Aug 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002157 Deep learning based automated epidermal growth factor receptor and anaplastic lymphoma kinase status prediction of brain metastasis in non-small cell lung cancer https://www.explorationpub.com/Journals/etat/Article/1002158 Not applicable. Original Article Thu, 31 Aug 2023 00:00:00 GMT Thu, 31 Aug 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002158 Deep learning based clinico-radiological model for paediatric brain tumor detection and subtype prediction https://www.explorationpub.com/Journals/etat/Article/1002159 Not applicable. Original Article Thu, 31 Aug 2023 00:00:00 GMT Thu, 31 Aug 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002159 Role of exosomes in transforming growth factor-β-mediated cancer cell plasticity and drug resistance https://www.explorationpub.com/Journals/etat/Article/1002322 Not applicable. Review Fri, 06 Jun 2025 00:00:00 GMT Fri, 06 Jun 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002322 Artificial intelligence ethics in precision oncology: balancing advancements in technology with patient privacy and autonomy https://www.explorationpub.com/Journals/etat/Article/1002160 Not applicable. Perspective Thu, 31 Aug 2023 00:00:00 GMT Thu, 31 Aug 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002160 Anticancer action of naturally occurring emodin for the controlling of cervical cancer https://www.explorationpub.com/Journals/etat/Article/1002161 Not applicable. Review Thu, 31 Aug 2023 00:00:00 GMT Thu, 31 Aug 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002161 Clinical and mutational profile of AT-rich interaction domain 1A-mutated cancers https://www.explorationpub.com/Journals/etat/Article/1002163 Not applicable. Original Article Thu, 31 Aug 2023 00:00:00 GMT Thu, 31 Aug 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002163 Protein ISGylation: a posttranslational modification with implications for malignant neoplasms https://www.explorationpub.com/Journals/etat/Article/1002162 Not applicable. Review Thu, 31 Aug 2023 00:00:00 GMT Thu, 31 Aug 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002162 Aflatoxin B1-DNA adducts modify the effects of post-operative adjuvant transarterial chemoembolization improving hepatocellular carcinoma prognosis https://www.explorationpub.com/Journals/etat/Article/1002167 Not applicable. Original Article Fri, 01 Sep 2023 00:00:00 GMT Fri, 01 Sep 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002167 In silico targeting of colony-stimulating factor-1 receptor: delineating immunotherapy in cancer https://www.explorationpub.com/Journals/etat/Article/1002164 Not applicable. Original Article Fri, 01 Sep 2023 00:00:00 GMT Fri, 01 Sep 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002164 Retrospective immunophenotypical evaluation of MET, PD-1/PD-L1, and mTOR pathways in primary tumors and pulmonary metastases of renal cell carcinoma: the RIVELATOR study addresses the issue of biomarkers heterogeneity https://www.explorationpub.com/Journals/etat/Article/1002165 Not applicable. Original Article Fri, 01 Sep 2023 00:00:00 GMT Fri, 01 Sep 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002165 Medicinal chemistry advances in targeting class I histone deacetylases https://www.explorationpub.com/Journals/etat/Article/1002166 Not applicable. Review Fri, 01 Sep 2023 00:00:00 GMT Fri, 01 Sep 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002166 A single experience in the conduction of clinical trial during COronaVIrusDisease-2019 pandemic https://www.explorationpub.com/Journals/etat/Article/1002168 Not applicable. Original Article Thu, 07 Sep 2023 00:00:00 GMT Thu, 07 Sep 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002168 Malignant tumors of the external auditory canal: diagnosis, treatment, genetic landscape, biomarkers, and clinical outcome https://www.explorationpub.com/Journals/etat/Article/1002169 Not applicable. Review Thu, 21 Sep 2023 00:00:00 GMT Thu, 21 Sep 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002169 Understanding the feasibility of chemotherapeutic and immunotherapeutic targets against non-small cell lung cancers: an update of resistant responses and recent combinatorial therapies https://www.explorationpub.com/Journals/etat/Article/1002171 Not applicable. Review Wed, 11 Oct 2023 00:00:00 GMT Wed, 11 Oct 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002171 Exploring the implications of modified advanced lung cancer inflammation index on outcomes in patients with advanced non-small cell lung cancer https://www.explorationpub.com/Journals/etat/Article/1002172 Not applicable. Original Article Wed, 11 Oct 2023 00:00:00 GMT Wed, 11 Oct 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002172 AGEs and RAGE: metabolic and molecular signatures of the glycation-inflammation axis in malignant or metastatic cancers https://www.explorationpub.com/Journals/etat/Article/1002170 Not applicable. Review Thu, 28 Sep 2023 00:00:00 GMT Thu, 28 Sep 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002170 Molecular interaction of metastasis suppressor genes and tumor microenvironment in breast cancer https://www.explorationpub.com/Journals/etat/Article/1002173 Not applicable. Review Thu, 12 Oct 2023 00:00:00 GMT Thu, 12 Oct 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002173 Current role of artificial intelligence in head and neck cancer surgery: a systematic review of literature https://www.explorationpub.com/Journals/etat/Article/1002174 Not applicable. Systematic Review Wed, 25 Oct 2023 00:00:00 GMT Wed, 25 Oct 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002174 Biomarkers in renal cell carcinoma and their targeted therapies: a review https://www.explorationpub.com/Journals/etat/Article/1002175 Not applicable. Review Wed, 25 Oct 2023 00:00:00 GMT Wed, 25 Oct 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002175 Melatonin, BAG-1 and cortisol circadian interactions in tumor pathogenesis and patterned immune responses https://www.explorationpub.com/Journals/etat/Article/1002176 Not applicable. Review Wed, 25 Oct 2023 00:00:00 GMT Wed, 25 Oct 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002176 A review on in silico virtual screening methods in COVID-19 using anticancer drugs and other natural/chemical inhibitors https://www.explorationpub.com/Journals/etat/Article/1002177 Not applicable. Review Thu, 26 Oct 2023 00:00:00 GMT Thu, 26 Oct 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002177 Integration of signaling pathway and bromodomain and extra-terminal domain inhibition for the treatment of mutant Kirsten rat sarcoma viral oncogene homolog cancer https://www.explorationpub.com/Journals/etat/Article/1002178 Not applicable. Review Thu, 26 Oct 2023 00:00:00 GMT Thu, 26 Oct 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002178 Effect of coronavirus disease 2019 on diagnosis and treatment of hepatocellular carcinoma: a systematic review https://www.explorationpub.com/Journals/etat/Article/1002179 Not applicable. Systematic Review Thu, 26 Oct 2023 00:00:00 GMT Thu, 26 Oct 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002179 Effect of vitamin D supplementation on inflammatory markers and total antioxidant capacity in breast cancer women using a machine learning technique https://www.explorationpub.com/Journals/etat/Article/1002180 Not applicable. Original Article Mon, 30 Oct 2023 00:00:00 GMT Mon, 30 Oct 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002180 Overcoming phenotypic switching: targeting protein-protein interactions in cancer https://www.explorationpub.com/Journals/etat/Article/1002181 Not applicable. Review Tue, 31 Oct 2023 00:00:00 GMT Tue, 31 Oct 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002181 Coronavirus disease 2019 and lung cancer: where are we? https://www.explorationpub.com/Journals/etat/Article/1002182 Not applicable. Review Tue, 31 Oct 2023 00:00:00 GMT Tue, 31 Oct 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002182 Impact of coronavirus disease 2019 pandemic on good clinical practice trials in oncology https://www.explorationpub.com/Journals/etat/Article/1002183 Not applicable. Systematic Review Tue, 31 Oct 2023 00:00:00 GMT Tue, 31 Oct 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002183 Acryl-3,5-bis(2,4-difluorobenzylidene)-4-piperidone targeting cellular JUN proto-oncogene, AP-1 transcription factor subunit inhibits head and neck squamous cell carcinoma progression https://www.explorationpub.com/Journals/etat/Article/1002184 Not applicable. Original Article Tue, 31 Oct 2023 00:00:00 GMT Tue, 31 Oct 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002184 Cholesterol esterification and p53-mediated tumor suppression https://www.explorationpub.com/Journals/etat/Article/1002185 Not applicable. Perspective Tue, 31 Oct 2023 00:00:00 GMT Tue, 31 Oct 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002185 A decade of CD4+ chimeric antigen receptor T-cell evolution in two chronic lymphocytic leukemia patients: were chronic lymphocytic leukemia cells present? https://www.explorationpub.com/Journals/etat/Article/1002186 Not applicable. Commentary Wed, 01 Nov 2023 00:00:00 GMT Wed, 01 Nov 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002186 Comparing efficacy and safety of upfront treatment strategies for anaplastic lymphoma kinase-positive non-small cell lung cancer: a network meta-analysis https://www.explorationpub.com/Journals/etat/Article/1002187 Not applicable. Meta-Analysis Fri, 01 Dec 2023 00:00:00 GMT Fri, 01 Dec 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002187 Chimeric single-chain variable fragment-human immunoglobulin G crystallizable fragment antibody against GD2 for neuroblastoma targeted immunotherapy https://www.explorationpub.com/Journals/etat/Article/1002188 Not applicable. Original Article Wed, 06 Dec 2023 00:00:00 GMT Wed, 06 Dec 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002188 Unexpected “Lazarus response” to single-agent bevacizumab in heavily pretreated patients with HER2-positive breast cancer https://www.explorationpub.com/Journals/etat/Article/1002189 Not applicable. Case Report Wed, 06 Dec 2023 00:00:00 GMT Wed, 06 Dec 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002189 Targeting cancer stem cell plasticity in triple-negative breast cancer https://www.explorationpub.com/Journals/etat/Article/1002190 Not applicable. Review Mon, 11 Dec 2023 00:00:00 GMT Mon, 11 Dec 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002190 Is oligoprogression a potentially curable disease in epidermal growth factor receptor mutant lung adenocarcinoma? https://www.explorationpub.com/Journals/etat/Article/1002191 Not applicable. Case Report Wed, 13 Dec 2023 00:00:00 GMT Wed, 13 Dec 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002191 Receptor tyrosine kinase-like orphan receptor 1 inhibitor strictinin exhibits anti-cancer properties against highly aggressive androgen-independent prostate cancer https://www.explorationpub.com/Journals/etat/Article/1002192 Not applicable. Original Article Thu, 21 Dec 2023 00:00:00 GMT Thu, 21 Dec 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002192 Investigations of the novel checkpoint kinase 1 inhibitor SRA737 in non-small cell lung cancer and colorectal cancer cells of differing tumour protein 53 gene status https://www.explorationpub.com/Journals/etat/Article/1002193 Not applicable. Original Article Thu, 21 Dec 2023 00:00:00 GMT Thu, 21 Dec 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002193 Recent advancements in targeted protein knockdown technologies—emerging paradigms for targeted therapy https://www.explorationpub.com/Journals/etat/Article/1002194 Not applicable. Review Tue, 26 Dec 2023 00:00:00 GMT Tue, 26 Dec 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002194 Telehealth in breast cancer following the coronavirus disease 2019 pandemic https://www.explorationpub.com/Journals/etat/Article/1002195 Not applicable. Review Wed, 27 Dec 2023 00:00:00 GMT Wed, 27 Dec 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002195 Post-translational modulation of cell signalling through protein succinylation https://www.explorationpub.com/Journals/etat/Article/1002196 Not applicable. Review Wed, 27 Dec 2023 00:00:00 GMT Wed, 27 Dec 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002196 Current implications and challenges of artificial intelligence technologies in therapeutic intervention of colorectal cancer https://www.explorationpub.com/Journals/etat/Article/1002197 Not applicable. Review Wed, 27 Dec 2023 00:00:00 GMT Wed, 27 Dec 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002197 Facing the conundrum: which first-line therapy should be used for patients with metastatic triple-negative breast cancer carrying germline BRCA mutation? https://www.explorationpub.com/Journals/etat/Article/1002198 Not applicable. Perspective Thu, 28 Dec 2023 00:00:00 GMT Thu, 28 Dec 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002198 Therapeutic significance of tumor microenvironment in cholangiocarcinoma: focus on tumor-infiltrating T lymphocytes https://www.explorationpub.com/Journals/etat/Article/1002199 Not applicable. Review Thu, 28 Dec 2023 00:00:00 GMT Thu, 28 Dec 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002199 Cola rostrata K. Schum. constituents induce cytotoxicity through reactive oxygen species generation and mitochondrial membrane depolarisation https://www.explorationpub.com/Journals/etat/Article/1002200 Not applicable. Original Article Fri, 29 Dec 2023 00:00:00 GMT Fri, 29 Dec 2023 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002200 Identification of lysyl oxidase as an adipocyte-secreted mediator that promotes a partial mesenchymal-to-epithelial transition in MDA-MB-231 cells https://www.explorationpub.com/Journals/etat/Article/1002201 Not applicable. Original Article Tue, 16 Jan 2024 00:00:00 GMT Tue, 16 Jan 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002201 Role of STAT3 in pancreatic cancer https://www.explorationpub.com/Journals/etat/Article/1002202 Not applicable. Review Wed, 17 Jan 2024 00:00:00 GMT Wed, 17 Jan 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002202 DNA methylation modulates epigenetic regulation in colorectal cancer diagnosis, prognosis and precision medicine https://www.explorationpub.com/Journals/etat/Article/1002203 Not applicable. Review Mon, 29 Jan 2024 00:00:00 GMT Mon, 29 Jan 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002203 Efficacy of metformin and electrical pulses in breast cancer MDA-MB-231 cells https://www.explorationpub.com/Journals/etat/Article/1002204 Not applicable. Original Article Mon, 19 Feb 2024 00:00:00 GMT Mon, 19 Feb 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002204 Pancreatic cancer: failures and hopes—a review of new promising treatment approaches https://www.explorationpub.com/Journals/etat/Article/1002299 Not applicable. Review Tue, 18 Mar 2025 00:00:00 GMT Tue, 18 Mar 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002299 Quantitative peritumoral magnetic resonance imaging fingerprinting improves machine learning-based prediction of overall survival in colorectal cancer https://www.explorationpub.com/Journals/etat/Article/1002205 Not applicable. Original Article Mon, 19 Feb 2024 00:00:00 GMT Mon, 19 Feb 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002205 Management of stage III non-small-cell lung cancer: rays of hope https://www.explorationpub.com/Journals/etat/Article/1002206 Not applicable. Mini Review Mon, 19 Feb 2024 00:00:00 GMT Mon, 19 Feb 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002206 CD99 tumor associated antigen is a potential target for antibody therapy of T-cell acute lymphoblastic leukemia https://www.explorationpub.com/Journals/etat/Article/1002207 Not applicable. Review Mon, 19 Feb 2024 00:00:00 GMT Mon, 19 Feb 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002207 Exploring the function of myeloid cells in promoting metastasis in head and neck cancer https://www.explorationpub.com/Journals/etat/Article/1002208 Not applicable. Mini Review Mon, 19 Feb 2024 00:00:00 GMT Mon, 19 Feb 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002208 The oncogenic role of hepatitis B virus X gene in hepatocarcinogenesis: recent updates https://www.explorationpub.com/Journals/etat/Article/1002209 Not applicable. Review Tue, 20 Feb 2024 00:00:00 GMT Tue, 20 Feb 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002209 Exploring monocarboxylate transporter inhibition for cancer treatment https://www.explorationpub.com/Journals/etat/Article/1002210 Not applicable. Review Fri, 23 Feb 2024 00:00:00 GMT Fri, 23 Feb 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002210 Conceptual breakthroughs of the long noncoding RNA functional system and its endogenous regulatory role in the cancerous regime https://www.explorationpub.com/Journals/etat/Article/1002211 Not applicable. Review Wed, 28 Feb 2024 00:00:00 GMT Wed, 28 Feb 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002211 Recent preclinical and clinical advances in radioimmunotherapy for non-Hodgkin’s lymphoma https://www.explorationpub.com/Journals/etat/Article/1002213 Not applicable. Review Wed, 28 Feb 2024 00:00:00 GMT Wed, 28 Feb 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002213 A case of immunotherapy-induced thyroiditis https://www.explorationpub.com/Journals/etat/Article/1002214 Not applicable. Case Report Wed, 28 Feb 2024 00:00:00 GMT Wed, 28 Feb 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002214 Early-stage triple negative breast cancer: the therapeutic role of immunotherapy and the prognostic value of pathological complete response https://www.explorationpub.com/Journals/etat/Article/1002215 Not applicable. Review Wed, 28 Feb 2024 00:00:00 GMT Wed, 28 Feb 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002215 Potential of targeting signal-transducing adaptor protein-2 in cancer therapeutic applications https://www.explorationpub.com/Journals/etat/Article/1002216 Not applicable. Mini Review Fri, 08 Mar 2024 00:00:00 GMT Fri, 08 Mar 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002216 Improving the quality of patient care in lung cancer: key factors for successful multidisciplinary team working https://www.explorationpub.com/Journals/etat/Article/1002217 Not applicable. Review Thu, 21 Mar 2024 00:00:00 GMT Thu, 21 Mar 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002217 Hexachlorobenzene as a differential modulator of the conventional and metronomic chemotherapy response in triple negative breast cancer cells https://www.explorationpub.com/Journals/etat/Article/1002218 Not applicable. Original Article Fri, 22 Mar 2024 00:00:00 GMT Fri, 22 Mar 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002218 Emerging roles of type 1 innate lymphoid cells in tumour pathogenesis and cancer immunotherapy https://www.explorationpub.com/Journals/etat/Article/1002219 Not applicable. Review Tue, 23 Apr 2024 00:00:00 GMT Tue, 23 Apr 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002219 Artificial intelligence and classification of mature lymphoid neoplasms https://www.explorationpub.com/Journals/etat/Article/1002221 Not applicable. Perspective Wed, 24 Apr 2024 00:00:00 GMT Wed, 24 Apr 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002221 Tumor metabolism in pheochromocytomas: clinical and therapeutic implications https://www.explorationpub.com/Journals/etat/Article/1002222 Not applicable. Review Wed, 24 Apr 2024 00:00:00 GMT Wed, 24 Apr 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002222 Improving single nucleotide polymorphisms genotyping accuracy for dihydropyrimidine dehydrogenase testing in pharmacogenetics https://www.explorationpub.com/Journals/etat/Article/1002223 Not applicable. Case Report Wed, 24 Apr 2024 00:00:00 GMT Wed, 24 Apr 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002223 Alteration of glucose metabolism and expression of glucose transporters in ovarian cancer https://www.explorationpub.com/Journals/etat/Article/1002224 Not applicable. Review Wed, 24 Apr 2024 00:00:00 GMT Wed, 24 Apr 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002224 Cancer symptom cluster research in pediatric oncology: a work in progress https://www.explorationpub.com/Journals/etat/Article/1002225 Not applicable. Perspective Wed, 24 Apr 2024 00:00:00 GMT Wed, 24 Apr 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002225 Spheroids and organoids derived from colorectal cancer as tools for in vitro drug screening https://www.explorationpub.com/Journals/etat/Article/1002226 Not applicable. Review Thu, 25 Apr 2024 00:00:00 GMT Thu, 25 Apr 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002226 Tri-specific killer engager: unleashing multi-synergic power against cancer https://www.explorationpub.com/Journals/etat/Article/1002227 Not applicable. Review Fri, 26 Apr 2024 00:00:00 GMT Fri, 26 Apr 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002227 Management of oligometastatic and oligoprogressive epidermal growth factor receptor mutated non-small cell lung cancer patients: state of the art of a combined approach https://www.explorationpub.com/Journals/etat/Article/1002228 Not applicable. Review Fri, 17 May 2024 00:00:00 GMT Fri, 17 May 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002228 Immunotherapy in thymic epithelial tumors: tissue predictive biomarkers for immune checkpoint inhibitors https://www.explorationpub.com/Journals/etat/Article/1002229 Not applicable. Perspective Tue, 21 May 2024 00:00:00 GMT Tue, 21 May 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002229 Advancements and recent explorations of anti-cancer activity of chrysin: from molecular targets to therapeutic perspective https://www.explorationpub.com/Journals/etat/Article/1002230 Not applicable. Review Thu, 23 May 2024 00:00:00 GMT Thu, 23 May 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002230 Resistance to immune checkpoint inhibitors in colorectal cancer with deficient mismatch repair/microsatellite instability: misdiagnosis, pseudoprogression and/or tumor heterogeneity? https://www.explorationpub.com/Journals/etat/Article/1002231 Not applicable. Perspective Thu, 23 May 2024 00:00:00 GMT Thu, 23 May 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002231 Chemotherapy related changes in cfDNA levels in squamous non-small cell lung cancer: correlation with symptom scores and radiological responses https://www.explorationpub.com/Journals/etat/Article/1002232 Not applicable. Original Article Tue, 28 May 2024 00:00:00 GMT Tue, 28 May 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002232 Cadmium nanocluster as a safe nanocarrier: biodistribution in BALB/c mice and application to carry crocin to breast cancer cell lines https://www.explorationpub.com/Journals/etat/Article/1002233 Not applicable. Original Article Tue, 28 May 2024 00:00:00 GMT Tue, 28 May 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002233 Practical implications of androgen receptor inhibitors for prostate cancer treatment https://www.explorationpub.com/Journals/etat/Article/1002234 Not applicable. Perspective Tue, 28 May 2024 00:00:00 GMT Tue, 28 May 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002234 Evaluation of molecular effects associated with apoptosis, tumour progression, angiogenesis and metastasis by a novel combination of drugs with ormeloxifene in triple negative breast cancer cells https://www.explorationpub.com/Journals/etat/Article/1002235 Not applicable. Original Article Tue, 11 Jun 2024 00:00:00 GMT Tue, 11 Jun 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002235 Anti-PD-1/L1 antibody plus anti-VEGF antibody vs. plus VEGFR-targeted TKI as first-line therapy for unresectable hepatocellular carcinoma: a network meta-analysis https://www.explorationpub.com/Journals/etat/Article/1002236 Not applicable. Meta-Analysis Mon, 17 Jun 2024 00:00:00 GMT Mon, 17 Jun 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002236 Comparison of primary and passaged tumor cell cultures and their application in personalized medicine https://www.explorationpub.com/Journals/etat/Article/1002237 Not applicable. Review Mon, 17 Jun 2024 00:00:00 GMT Mon, 17 Jun 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002237 Evaluation of antitumor potential of an anti-glypican-1 monoclonal antibody in preclinical lung cancer models reveals a distinct mechanism of action https://www.explorationpub.com/Journals/etat/Article/1002238 Not applicable. Original Article Tue, 18 Jun 2024 00:00:00 GMT Tue, 18 Jun 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002238 Clinical relevance of circulating tumor DNA in ovarian cancer: current issues and future opportunities https://www.explorationpub.com/Journals/etat/Article/1002239 Not applicable. Review Wed, 19 Jun 2024 00:00:00 GMT Wed, 19 Jun 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002239 Landscape of targeted therapies for advanced urothelial carcinoma https://www.explorationpub.com/Journals/etat/Article/1002240 Not applicable. Review Fri, 21 Jun 2024 00:00:00 GMT Fri, 21 Jun 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002240 DNA damage targeted therapy for advanced breast cancer https://www.explorationpub.com/Journals/etat/Article/1002241 Not applicable. Review Tue, 25 Jun 2024 00:00:00 GMT Tue, 25 Jun 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002241 Promising immunotherapeutic approaches for primary effusion lymphoma https://www.explorationpub.com/Journals/etat/Article/1002242 Not applicable. Review Wed, 26 Jun 2024 00:00:00 GMT Wed, 26 Jun 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002242 Current status of molecular diagnostics for lung cancer https://www.explorationpub.com/Journals/etat/Article/1002244 Not applicable. Review Thu, 27 Jun 2024 00:00:00 GMT Thu, 27 Jun 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002244 Antibody-drug conjugates combinations in cancer treatment https://www.explorationpub.com/Journals/etat/Article/1002243 Not applicable. Review Thu, 27 Jun 2024 00:00:00 GMT Thu, 27 Jun 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002243 Imaging of supratentorial ependymomas with radio-pathological correlation https://www.explorationpub.com/Journals/etat/Article/1002245 Not applicable. Original Article Thu, 27 Jun 2024 00:00:00 GMT Thu, 27 Jun 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002245 Response to trametinib, hydroxychloroquine, and bevacizumab in a young woman with NRAS-mutated metastatic intrahepatic cholangiocarcinoma: a case report https://www.explorationpub.com/Journals/etat/Article/1002246 Not applicable. Case Report Fri, 28 Jun 2024 00:00:00 GMT Fri, 28 Jun 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002246 Selected meeting abstracts of 2nd International Conference on Contemporary Oncology https://www.explorationpub.com/Journals/etat/Article/1002247 Not applicable. Meeting Abstracts Fri, 28 Jun 2024 00:00:00 GMT Fri, 28 Jun 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002247 Correction: Deep learning based automated epidermal growth factor receptor and anaplastic lymphoma kinase status prediction of brain metastasis in non-small cell lung cancer https://www.explorationpub.com/Journals/etat/Article/1002248 Not applicable. Correction Mon, 08 Jul 2024 00:00:00 GMT Mon, 08 Jul 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002248 Immunopeptidomics in the cancer immunotherapy era https://www.explorationpub.com/Journals/etat/Article/1002249 Not applicable. Review Wed, 17 Jul 2024 00:00:00 GMT Wed, 17 Jul 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002249 Immune checkpoint inhibitor-induced cholangitis—a three-case series https://www.explorationpub.com/Journals/etat/Article/1002250 Not applicable. Case Report Fri, 19 Jul 2024 00:00:00 GMT Fri, 19 Jul 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002250 It might be a dead end: immune checkpoint inhibitor therapy in EGFR-mutated NSCLC https://www.explorationpub.com/Journals/etat/Article/1002251 Not applicable. Review Fri, 19 Jul 2024 00:00:00 GMT Fri, 19 Jul 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002251 Regulatory RNAs: role as scaffolds assembling protein complexes and their epigenetic deregulation https://www.explorationpub.com/Journals/etat/Article/1002252 Not applicable. Review Mon, 22 Jul 2024 00:00:00 GMT Mon, 22 Jul 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002252 The genomic and molecular landscape of splenic marginal zone lymphoma, biological and clinical implications https://www.explorationpub.com/Journals/etat/Article/1002253 Not applicable. Review Tue, 23 Jul 2024 00:00:00 GMT Tue, 23 Jul 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002253 A narrative review on perioperative systemic therapy in non-small cell lung cancer https://www.explorationpub.com/Journals/etat/Article/1002256 Not applicable. Review Fri, 26 Jul 2024 00:00:00 GMT Fri, 26 Jul 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002256 Hepatobiliary complications of immune checkpoint inhibitors in cancer https://www.explorationpub.com/Journals/etat/Article/1002257 Not applicable. Review Fri, 26 Jul 2024 00:00:00 GMT Fri, 26 Jul 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002257 Risk factors for Gleason score upgrade from prostate biopsy to radical prostatectomy https://www.explorationpub.com/Journals/etat/Article/1002259 Not applicable. Review Wed, 31 Jul 2024 00:00:00 GMT Wed, 31 Jul 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002259 Therapy-induced senescence in breast cancer: an overview https://www.explorationpub.com/Journals/etat/Article/1002254 Not applicable. Review Fri, 26 Jul 2024 00:00:00 GMT Fri, 26 Jul 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002254 Oligometastatic esophageal cancer cured by systemic therapy combined with radiotherapy to primary tumor and metastasis (metastasis-directed therapy)—small case series https://www.explorationpub.com/Journals/etat/Article/1002255 Not applicable. Case Report Fri, 26 Jul 2024 00:00:00 GMT Fri, 26 Jul 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002255 The rapidly changing treatment landscape of first-line advanced urothelial cancer (aUC) or metastatic urothelial cancer (mUC) https://www.explorationpub.com/Journals/etat/Article/1002258 Not applicable. Commentary Mon, 29 Jul 2024 00:00:00 GMT Mon, 29 Jul 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002258 GPCRs as targets for flavonoids in cancer cells: new options for intervention https://www.explorationpub.com/Journals/etat/Article/1002268 Not applicable. Review Fri, 30 Aug 2024 00:00:00 GMT Fri, 30 Aug 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002268 Combination of the PARPi and ARSi in advanced castration resistant prostate cancer: a review of the recent phase III trials https://www.explorationpub.com/Journals/etat/Article/1002260 Not applicable. Review Fri, 02 Aug 2024 00:00:00 GMT Fri, 02 Aug 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002260 Prospects for breast cancer immunotherapy using microRNAs and transposable elements as objects https://www.explorationpub.com/Journals/etat/Article/1002261 Not applicable. Review Tue, 06 Aug 2024 00:00:00 GMT Tue, 06 Aug 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002261 Hematopoietic and leukemic stem cells homeostasis: the role of bone marrow niche https://www.explorationpub.com/Journals/etat/Article/1002262 Not applicable. Review Thu, 15 Aug 2024 00:00:00 GMT Thu, 15 Aug 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002262 Harnessing endoscopic ultrasound-guided radiofrequency ablation to reshape the pancreatic ductal adenocarcinoma microenvironment and elicit systemic immunomodulation https://www.explorationpub.com/Journals/etat/Article/1002263 Not applicable. Review Fri, 16 Aug 2024 00:00:00 GMT Fri, 16 Aug 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002263 Anticancer peptides as novel immunomodulatory therapeutic candidates for cancer treatment https://www.explorationpub.com/Journals/etat/Article/1002264 Not applicable. Review Thu, 22 Aug 2024 00:00:00 GMT Thu, 22 Aug 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002264 Evaluation of HER2 immunohistochemistry expression in non-standard solid tumors from a Single-Institution Prospective Cohort https://www.explorationpub.com/Journals/etat/Article/1002265 Not applicable. Original Article Fri, 23 Aug 2024 00:00:00 GMT Fri, 23 Aug 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002265 Emerging molecular therapies in the treatment of bladder cancer https://www.explorationpub.com/Journals/etat/Article/1002267 Not applicable. Review Fri, 30 Aug 2024 00:00:00 GMT Fri, 30 Aug 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002267 Therapy resistance in prostate cancer: mechanism, signaling and reversal strategies https://www.explorationpub.com/Journals/etat/Article/1002266 Not applicable. Review Thu, 29 Aug 2024 00:00:00 GMT Thu, 29 Aug 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002266 Diagnostic and prognostic role of NLR in testicular cancer https://www.explorationpub.com/Journals/etat/Article/1002270 Not applicable. Systematic Review Fri, 20 Sep 2024 00:00:00 GMT Fri, 20 Sep 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002270 Diagnostic utility of prostate health index density prior to MRI-ultrasound fusion targeted biopsy https://www.explorationpub.com/Journals/etat/Article/1002269 Not applicable. Original Article Sat, 14 Sep 2024 00:00:00 GMT Sat, 14 Sep 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002269 Blood-based circulating biomarkers for prediction of immune-checkpoint inhibitors efficacy in renal cell carcinoma https://www.explorationpub.com/Journals/etat/Article/1002271 Not applicable. Review Fri, 20 Sep 2024 00:00:00 GMT Fri, 20 Sep 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002271 Exploring the therapeutic potential of lipid-based nanoparticles in the management of oral squamous cell carcinoma https://www.explorationpub.com/Journals/etat/Article/1002272 Not applicable. Review Mon, 30 Sep 2024 00:00:00 GMT Mon, 30 Sep 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002272 Evidence for the evolving role of neoadjuvant and perioperative immunotherapy in resectable non-small cell lung cancer https://www.explorationpub.com/Journals/etat/Article/1002273 Not applicable. Review Mon, 30 Sep 2024 00:00:00 GMT Mon, 30 Sep 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002273 Upper tract urothelial cancer (UTUC) genomic profiling and correlation regarding benefit of platinum-based chemotherapy https://www.explorationpub.com/Journals/etat/Article/1002274 Not applicable. Case Report Fri, 18 Oct 2024 00:00:00 GMT Fri, 18 Oct 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002274 Predictive markers of response to immune checkpoint inhibitor rechallenge in metastatic non-small cell lung cancer https://www.explorationpub.com/Journals/etat/Article/1002275 Not applicable. Original Article Fri, 18 Oct 2024 00:00:00 GMT Fri, 18 Oct 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002275 Preliminary evaluation of FAPI-04-PET/CT for differentiating recurrence and post-treatment changes in high-grade gliomas https://www.explorationpub.com/Journals/etat/Article/1002276 Not applicable. Short Communication Fri, 01 Nov 2024 00:00:00 GMT Fri, 01 Nov 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002276 Addressing the unmet need in NSCLC progression with advances in second-line therapeutics https://www.explorationpub.com/Journals/etat/Article/1002277 Not applicable. Review Fri, 01 Nov 2024 00:00:00 GMT Fri, 01 Nov 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002277 Predictive and prognostic biomarkers in cancer: towards the precision medicine era https://www.explorationpub.com/Journals/etat/Article/1002278 Not applicable. Editorial Wed, 20 Nov 2024 00:00:00 GMT Wed, 20 Nov 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002278 Targeted therapies and molecular targets in the therapeutic landscape of advanced urothelial carcinoma: state of the art and future perspectives https://www.explorationpub.com/Journals/etat/Article/1002279 Not applicable. Review Thu, 21 Nov 2024 00:00:00 GMT Thu, 21 Nov 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002279 The promises and perils of circulating tumor DNA for monitoring immunotherapy response in non-small cell lung cancer https://www.explorationpub.com/Journals/etat/Article/1002280 Not applicable. Perspective Tue, 26 Nov 2024 00:00:00 GMT Tue, 26 Nov 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002280 Curative immunotherapy-based strategies for non-metastatic non-small cell lung cancer https://www.explorationpub.com/Journals/etat/Article/1002281 Not applicable. Review Fri, 06 Dec 2024 00:00:00 GMT Fri, 06 Dec 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002281 Nigerian medicinal plants with potential anticancer activity—a review https://www.explorationpub.com/Journals/etat/Article/1002282 Not applicable. Review Mon, 09 Dec 2024 00:00:00 GMT Mon, 09 Dec 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002282 Analysis of the benefit of anti-PD-1 monotherapy according to NGS-diagnosed genetic alterations in patients with non-small cell lung cancer https://www.explorationpub.com/Journals/etat/Article/1002283 Not applicable. Original Article Wed, 18 Dec 2024 00:00:00 GMT Wed, 18 Dec 2024 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002283 Assessment of lipid peroxidation and total antioxidant capacity in patients with breast cancer https://www.explorationpub.com/Journals/etat/Article/1002284 Not applicable. Original Article Fri, 03 Jan 2025 00:00:00 GMT Fri, 03 Jan 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002284 Implications of noncoding RNAs for cancer therapy: Are we aiming at the right targets? https://www.explorationpub.com/Journals/etat/Article/1002286 Not applicable. Perspective Thu, 16 Jan 2025 00:00:00 GMT Thu, 16 Jan 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002286 Concomitant exposure to benzodiazepines during pembrolizumab-based therapy for advanced non-small-cell lung cancer: a propensity-score matched analysis of monitoring agency data https://www.explorationpub.com/Journals/etat/Article/1002287 Not applicable. Original Article Mon, 20 Jan 2025 00:00:00 GMT Mon, 20 Jan 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002287 Neoantigen immunotherapy: a novel treatment for bladder cancer https://www.explorationpub.com/Journals/etat/Article/1002288 Not applicable. Review Sun, 26 Jan 2025 00:00:00 GMT Sun, 26 Jan 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002288 Shorter telomere length as a prognostic marker for survival and recurrence in breast cancer: a systematic review and meta-analysis https://www.explorationpub.com/Journals/etat/Article/1002289 Not applicable. Meta-Analysis Fri, 14 Feb 2025 00:00:00 GMT Fri, 14 Feb 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002289 Non-targeted effects of stereotactic radiotherapy: a review of the evidence coming from the clinical field https://www.explorationpub.com/Journals/etat/Article/1002290 Not applicable. Systematic Review Fri, 14 Feb 2025 00:00:00 GMT Fri, 14 Feb 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002290 Multikinase and highly selective kinase inhibitors in the neoadjuvant treatment of patients with thyroid cancer https://www.explorationpub.com/Journals/etat/Article/1002291 Not applicable. Review Fri, 14 Feb 2025 00:00:00 GMT Fri, 14 Feb 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002291 Releasing the brakes: the role of immune checkpoint inhibitors in laryngeal cancer https://www.explorationpub.com/Journals/etat/Article/1002292 Not applicable. Review Tue, 18 Feb 2025 00:00:00 GMT Tue, 18 Feb 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002292 Elacestrant in hormone receptor-positive metastatic breast cancer: a post-hoc analysis https://www.explorationpub.com/Journals/etat/Article/1002293 Not applicable. Meta-Analysis Fri, 21 Feb 2025 00:00:00 GMT Fri, 21 Feb 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002293 Unmasking the potential: mechanisms of neuroinflammatory modulation by oncolytic viruses in glioblastoma https://www.explorationpub.com/Journals/etat/Article/1002294 Not applicable. Review Tue, 25 Feb 2025 00:00:00 GMT Tue, 25 Feb 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002294 Herbal based nanoparticles as a possible and potential treatment of cancer: a review https://www.explorationpub.com/Journals/etat/Article/1002285 Not applicable. Review Fri, 03 Jan 2025 00:00:00 GMT Fri, 03 Jan 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002285 Genomic alterations in the WNT/β-catenin pathway and resistance of colorectal cancer cells to pathway-targeting therapies https://www.explorationpub.com/Journals/etat/Article/1002295 Not applicable. Original Article Wed, 26 Feb 2025 00:00:00 GMT Wed, 26 Feb 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002295 Immunotherapy in cervical cancer: an innovative approach for better treatment outcomes https://www.explorationpub.com/Journals/etat/Article/1002296 Not applicable. Review Mon, 03 Mar 2025 00:00:00 GMT Mon, 03 Mar 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002296 Metabolic mechanisms of immunotherapy resistance https://www.explorationpub.com/Journals/etat/Article/1002297 Not applicable. Review Fri, 14 Mar 2025 00:00:00 GMT Fri, 14 Mar 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002297 Overview on biomarkers for immune oncology drugs https://www.explorationpub.com/Journals/etat/Article/1002298 Not applicable. Review Mon, 17 Mar 2025 00:00:00 GMT Mon, 17 Mar 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002298 A systematic review and meta-analysis of phase III randomized controlled trials to assess the risk of pneumonia, URTIs, and VTE in multiple myeloma patients treated with isatuximab https://www.explorationpub.com/Journals/etat/Article/1002300 Not applicable. Meta-Analysis Thu, 20 Mar 2025 00:00:00 GMT Thu, 20 Mar 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002300 Bladder cancer biomarkers https://www.explorationpub.com/Journals/etat/Article/1002301 Not applicable. Review Tue, 25 Mar 2025 00:00:00 GMT Tue, 25 Mar 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002301 Advances in adoptive cell therapies in small cell lung cancer https://www.explorationpub.com/Journals/etat/Article/1002302 Not applicable. Review Wed, 26 Mar 2025 00:00:00 GMT Wed, 26 Mar 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002302 Nanoimmunotherapy: the smart trooper for cancer therapy https://www.explorationpub.com/Journals/etat/Article/1002308 Not applicable. Review Fri, 11 Apr 2025 00:00:00 GMT Fri, 11 Apr 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002308 State-of-the-art photodynamic therapy for malignant gliomas: innovations in photosensitizers and combined therapeutic approaches https://www.explorationpub.com/Journals/etat/Article/1002303 Not applicable. Review Fri, 28 Mar 2025 00:00:00 GMT Fri, 28 Mar 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002303 Key immune cells and their crosstalk in the tumor microenvironment of bladder cancer: insights for innovative therapies https://www.explorationpub.com/Journals/etat/Article/1002304 Not applicable. Review Tue, 01 Apr 2025 00:00:00 GMT Tue, 01 Apr 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002304 Exploring recent advances in signaling pathways and hallmarks of uveal melanoma: a comprehensive review https://www.explorationpub.com/Journals/etat/Article/1002306 Not applicable. Review Wed, 02 Apr 2025 00:00:00 GMT Wed, 02 Apr 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002306 Real-world outcomes of lenvatinib plus pembrolizumab in intermediate- and poor-risk metastatic renal cell carcinoma https://www.explorationpub.com/Journals/etat/Article/1002305 Not applicable. Short Communication Wed, 02 Apr 2025 00:00:00 GMT Wed, 02 Apr 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002305 Strategies to overcome resistance to enfortumab vedotin and pembrolizumab for patients with urothelial carcinoma: harnessing present knowledge for future advances https://www.explorationpub.com/Journals/etat/Article/1002307 Not applicable. Review Tue, 08 Apr 2025 00:00:00 GMT Tue, 08 Apr 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002307 Eosinophil cytolysis with or without ETosis in four cases of human gastric cancer: a comparative ultrastructural study https://www.explorationpub.com/Journals/etat/Article/1002309 Not applicable. Case Report Tue, 22 Apr 2025 00:00:00 GMT Tue, 22 Apr 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002309 Viral infections and immune modulation in bladder cancer: implications for immunotherapy https://www.explorationpub.com/Journals/etat/Article/1002311 Not applicable. Review Thu, 24 Apr 2025 00:00:00 GMT Thu, 24 Apr 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002311 Modulation of anti-tumour immunity by XPO1 inhibitors https://www.explorationpub.com/Journals/etat/Article/1002310 Not applicable. Review Thu, 24 Apr 2025 00:00:00 GMT Thu, 24 Apr 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002310 Neoantigen-based immunotherapy: advancing precision medicine in cancer and glioblastoma treatment through discovery and innovation https://www.explorationpub.com/Journals/etat/Article/1002313 Not applicable. Review Sun, 27 Apr 2025 00:00:00 GMT Sun, 27 Apr 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002313 Cytokine-based immunotherapy for gastric cancer: targeting inflammation for tumor control https://www.explorationpub.com/Journals/etat/Article/1002312 Not applicable. Review Sun, 27 Apr 2025 00:00:00 GMT Sun, 27 Apr 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002312 Utility of CA-125 for diagnosis and prognosis of breast cancer: a systematic review https://www.explorationpub.com/Journals/etat/Article/1002316 Not applicable. Systematic Review Thu, 15 May 2025 00:00:00 GMT Thu, 15 May 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002316 Harnessing the power of tumor-draining lymph nodes: unveiling predictive biomarkers for immune checkpoint inhibitor https://www.explorationpub.com/Journals/etat/Article/1002315 Not applicable. Review Tue, 13 May 2025 00:00:00 GMT Tue, 13 May 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002315 The development and applications of circulating tumour cells, circulating tumour DNA and other emerging biomarkers for early cancer detection https://www.explorationpub.com/Journals/etat/Article/1002314 Not applicable. Review Tue, 13 May 2025 00:00:00 GMT Tue, 13 May 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002314 The role of circulating tumor DNA (ctDNA) in urothelial cancers https://www.explorationpub.com/Journals/etat/Article/1002317 Not applicable. Commentary Tue, 20 May 2025 00:00:00 GMT Tue, 20 May 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002317 The DNA methylation landscape of musculoskeletal sarcomas https://www.explorationpub.com/Journals/etat/Article/1002319 Not applicable. Review Mon, 26 May 2025 00:00:00 GMT Mon, 26 May 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002319 Prognostic impact of biomarkers in PMBCL: rationale for early integration of immune checkpoint inhibitors https://www.explorationpub.com/Journals/etat/Article/1002318 Not applicable. Original Article Wed, 21 May 2025 00:00:00 GMT Wed, 21 May 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002318 A viral circular RNA in Kaposi’s sarcoma-associated herpesvirus modulates viral and host gene expression during latent and lytic replication https://www.explorationpub.com/Journals/etat/Article/1002320 Not applicable. Original Article Thu, 29 May 2025 00:00:00 GMT Thu, 29 May 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002320 Circulating tumor cells: overcoming challenges of detecting a needle in a haystack https://www.explorationpub.com/Journals/etat/Article/1002321 Not applicable. Review Fri, 30 May 2025 00:00:00 GMT Fri, 30 May 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002321 Mutational landscape of epidermoid carcinoma of the penis in a Brazilian cohort https://www.explorationpub.com/Journals/etat/Article/1002323 Not applicable. Original Article Fri, 06 Jun 2025 00:00:00 GMT Fri, 06 Jun 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002323 Osteosarcoma: current insights and advances https://www.explorationpub.com/Journals/etat/Article/1002324 Not applicable. Review Mon, 16 Jun 2025 00:00:00 GMT Mon, 16 Jun 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002324 Comparison of outcomes of neoadjuvant chemotherapy in BRCA1- versus BRCA2-associated breast and ovarian cancers https://www.explorationpub.com/Journals/etat/Article/1002325 Not applicable. Original Article Thu, 19 Jun 2025 00:00:00 GMT Thu, 19 Jun 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002325 Novel kinase-activating genetic events in non-small cell lung carcinomas https://www.explorationpub.com/Journals/etat/Article/1002330 Not applicable. Original Article Thu, 10 Jul 2025 00:00:00 GMT Thu, 10 Jul 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002330 An overview of the feasibility of nanomedicine in pancreatic cancer theranostics https://www.explorationpub.com/Journals/etat/Article/1002326 Not applicable. Review Thu, 19 Jun 2025 00:00:00 GMT Thu, 19 Jun 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002326 Future perspectives: targeting fibroblast growth factor receptor 1 to enhance the efficacy of immunotherapy https://www.explorationpub.com/Journals/etat/Article/1002327 Not applicable. Perspective Fri, 20 Jun 2025 00:00:00 GMT Fri, 20 Jun 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002327 Biliary tract cancers: advances in diagnostic and management https://www.explorationpub.com/Journals/etat/Article/1002328 Not applicable. Review Tue, 24 Jun 2025 00:00:00 GMT Tue, 24 Jun 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002328 Dysbiosis and colorectal cancer: conducive factors, biological and molecular role, and therapeutic prospectives https://www.explorationpub.com/Journals/etat/Article/1002329 Not applicable. Review Fri, 27 Jun 2025 00:00:00 GMT Fri, 27 Jun 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002329 Correlation between histopathological features and recurrence score according to menopausal status in HR+/HER2– breast cancer patients: a retrospective study https://www.explorationpub.com/Journals/etat/Article/1002331 Not applicable. Original Article Fri, 18 Jul 2025 00:00:00 GMT Fri, 18 Jul 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002331 Retracted: Anti-angiogenic effects of Moringa oleifera silver nanoparticles on endothelial cells: in vitro and ex vivo studies https://www.explorationpub.com/Journals/etat/Article/1002332 Not applicable. Original Article Mon, 28 Jul 2025 00:00:00 GMT Mon, 28 Jul 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002332 Improvement of the sensitivity of circulating tumor DNA-based liquid biopsy: current approaches and future perspectives https://www.explorationpub.com/Journals/etat/Article/1002333 Not applicable. Review Fri, 08 Aug 2025 00:00:00 GMT Fri, 08 Aug 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002333 Genetic and epigenetic landscape of O6-methylguanine-DNA methyltransferase (MGMT): implications for DNA repair and cancer therapeutics https://www.explorationpub.com/Journals/etat/Article/1002335 Not applicable. Review Fri, 29 Aug 2025 00:00:00 GMT Fri, 29 Aug 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002335 Inflammatory signatures across four photon radiotherapy and proton radiotherapy: mechanisms, mitigation, and quality of life impact https://www.explorationpub.com/Journals/etat/Article/1002334 Not applicable. Review Fri, 29 Aug 2025 00:00:00 GMT Fri, 29 Aug 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002334 Predictive value of 8-hydroxy-2′-deoxyguanosine and 8-nitroguanine production in radiation-induced skin damage after postoperative breast cancer radiotherapy https://www.explorationpub.com/Journals/etat/Article/1002336 Not applicable. Original Article Mon, 22 Sep 2025 00:00:00 GMT Mon, 22 Sep 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002336 Metabolic plasticity drives specific mechanisms of chemotherapy and targeted therapy resistance in metastatic colorectal cancer https://www.explorationpub.com/Journals/etat/Article/1002337 Not applicable. Review Tue, 23 Sep 2025 00:00:00 GMT Tue, 23 Sep 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002337 Engineered nanocarriers for targeted lung cancer therapy: mechanistic innovations and recent clinical progress https://www.explorationpub.com/Journals/etat/Article/1002339 Not applicable. Review Mon, 13 Oct 2025 00:00:00 GMT Mon, 13 Oct 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002339 Synergistic anticancer efficacy of optimized curcumin-piperine loaded magnetic nanoparticles for the treatment of colorectal cancer https://www.explorationpub.com/Journals/etat/Article/1002340 Not applicable. Original Article Tue, 21 Oct 2025 00:00:00 GMT Tue, 21 Oct 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002340 New approaches of green silver nanoparticles for cancer and biomedical applications: a review https://www.explorationpub.com/Journals/etat/Article/1002341 Not applicable. Review Thu, 23 Oct 2025 00:00:00 GMT Thu, 23 Oct 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002341 Differential molecular mechanisms of bortezomib sensitization to rhTRAIL in non-small cell lung cancer cell lines https://www.explorationpub.com/Journals/etat/Article/1002342 Not applicable. Original Article Wed, 29 Oct 2025 00:00:00 GMT Wed, 29 Oct 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002342 Racial disparities in hepatocellular carcinoma: a TCGA-based gene expression study of Caucasian and Asian populations https://www.explorationpub.com/Journals/etat/Article/1002344 Not applicable. Original Article Mon, 03 Nov 2025 00:00:00 GMT Mon, 03 Nov 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002344 Retraction: Anti-angiogenic effects of Moringa oleifera silver nanoparticles on endothelial cells: in vitro and ex vivo studies https://www.explorationpub.com/Journals/etat/Article/1002343 Not applicable. Retraction Wed, 29 Oct 2025 00:00:00 GMT Wed, 29 Oct 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002343 Bispecific antibodies in the treatment of epithelial ovarian, endometrial, and cervical cancer: an overview of current applications, challenges, and emerging opportunities https://www.explorationpub.com/Journals/etat/Article/1002345 Not applicable. Review Thu, 06 Nov 2025 00:00:00 GMT Thu, 06 Nov 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002345 Metal grafted graphene-based nanomaterials towards cancer theranostic efficacy https://www.explorationpub.com/Journals/etat/Article/1002346 Not applicable. Review Tue, 11 Nov 2025 00:00:00 GMT Tue, 11 Nov 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002346 Immune checkpoint inhibitor-induced hemophagocytic lymphohistiocytosis in lung cancer: a case series https://www.explorationpub.com/Journals/etat/Article/1002347 Not applicable. Case Report Wed, 12 Nov 2025 00:00:00 GMT Wed, 12 Nov 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002347 Role of microbiota in the outcome of immune checkpoint inhibition therapy of cancer https://www.explorationpub.com/Journals/etat/Article/1002348 Not applicable. Review Tue, 18 Nov 2025 00:00:00 GMT Tue, 18 Nov 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002348 Smart nanofluidic systems powered by DNA origami for targeted intracellular delivery: a newer approach https://www.explorationpub.com/Journals/etat/Article/1002349 Not applicable. Review Wed, 19 Nov 2025 00:00:00 GMT Wed, 19 Nov 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002349 Cancer vaccines: advances, hurdles, and future directions https://www.explorationpub.com/Journals/etat/Article/1002350 Not applicable. Review Mon, 24 Nov 2025 00:00:00 GMT Mon, 24 Nov 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002350 Unmasking the microbiome: the hidden role of gut bacteria in the pathogenesis of colorectal cancer and its prevention strategies https://www.explorationpub.com/Journals/etat/Article/1002351 Not applicable. Mini Review Tue, 25 Nov 2025 00:00:00 GMT Tue, 25 Nov 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002351 Optimizing procedures for ocular radiation injury studies in the tree shrew https://www.explorationpub.com/Journals/etat/Article/1002352 Not applicable. Protocol Tue, 02 Dec 2025 00:00:00 GMT Tue, 02 Dec 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002352 Conceptualization of fibroblast growth factor receptor 1 targeting nanomedicines https://www.explorationpub.com/Journals/etat/Article/1002353 Not applicable. Letter to the Editor Wed, 17 Dec 2025 00:00:00 GMT Wed, 17 Dec 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002353 Therapeutic properties of plant-derived prebiotics in melanoma https://www.explorationpub.com/Journals/etat/Article/1002354 Not applicable. Review Fri, 19 Dec 2025 00:00:00 GMT Fri, 19 Dec 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002354 Next-generation nanocarriers for precision antitumor therapy: from passive targeting to intelligent response https://www.explorationpub.com/Journals/etat/Article/1002355 Not applicable. Review Mon, 29 Dec 2025 00:00:00 GMT Mon, 29 Dec 2025 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002355 The critical need for robust decision support in the era of precision cancer therapeutics https://www.explorationpub.com/Journals/etat/Article/1002356 Not applicable. Editorial Thu, 22 Jan 2026 00:00:00 GMT Thu, 22 Jan 2026 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002356 Application of explainable artificial intelligence integrating with electronic health record in oncology https://www.explorationpub.com/Journals/etat/Article/1002357 Not applicable. Perspective Wed, 04 Feb 2026 00:00:00 GMT Wed, 04 Feb 2026 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002357 Glioblastoma pathophysiology: roles of aging driven changes in STAT3 interactions with NF-κB dimer components in the modulation of the mitochondrial melatonergic pathway and night-time inflammation resolution https://www.explorationpub.com/Journals/etat/Article/1002358 Not applicable. Review Fri, 13 Feb 2026 00:00:00 GMT Fri, 13 Feb 2026 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002358 Benign, persistent, and invasive: mechanistic and translational approaches to middle‑ear cholesteatoma https://www.explorationpub.com/Journals/etat/Article/1002359 Not applicable. Mini Review Wed, 25 Feb 2026 00:00:00 GMT Wed, 25 Feb 2026 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002359 Comparison of weekly docetaxel regimens in prostate cancer: a systematic review and frequentist network meta-analysis https://www.explorationpub.com/Journals/etat/Article/1002360 Not applicable. Systematic Review Fri, 27 Feb 2026 00:00:00 GMT Fri, 27 Feb 2026 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002360 Emerging roles of haemostatic proteins as markers of disease progression and prognosis in breast cancer https://www.explorationpub.com/Journals/etat/Article/1002361 Not applicable. Review Mon, 09 Mar 2026 00:00:00 GMT Mon, 09 Mar 2026 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002361 Survival prediction in triple-negative breast cancer: a Cox model with fairness assessment using ISO/IEC TR 24027:2021 in a MENA cohort https://www.explorationpub.com/Journals/etat/Article/1002362 Not applicable. Original Article Fri, 20 Mar 2026 00:00:00 GMT Fri, 20 Mar 2026 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002362 CHD4 and NOX4 expression in thyroid tumor tissues https://www.explorationpub.com/Journals/etat/Article/1002363 Not applicable. Original Article Thu, 26 Mar 2026 00:00:00 GMT Thu, 26 Mar 2026 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002363 Disrupting the TGF-β-regulated epithelial-mesenchymal transition, apoptotic and autophagic phenotypes of 3D glioblastoma spheroids via glycolytic inhibition https://www.explorationpub.com/Journals/etat/Article/1002364 Not applicable. Original Article Tue, 31 Mar 2026 00:00:00 GMT Tue, 31 Mar 2026 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002364 Changes of urinary immunity and microbiome after intravesical BCG therapy and their association with outcomes in NMIBC https://www.explorationpub.com/Journals/etat/Article/1002365 Not applicable. Original Article Tue, 14 Apr 2026 00:00:00 GMT Tue, 14 Apr 2026 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002365 Lorlatinib in advanced ALK-positive NSCLC after prior progression on ALK inhibitors: real-world experience in Russia https://www.explorationpub.com/Journals/etat/Article/1002366 Not applicable. Original Article Thu, 16 Apr 2026 00:00:00 GMT Thu, 16 Apr 2026 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002366 Solitary fibrous tumor of the lung: diagnostic challenges and surgical management https://www.explorationpub.com/Journals/etat/Article/1002367 Not applicable. Case Report Wed, 22 Apr 2026 00:00:00 GMT Wed, 22 Apr 2026 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002367 The evolving role of targeted radioligand therapy in small cell and non-small cell lung cancer: a systematic review https://www.explorationpub.com/Journals/etat/Article/1002368 Not applicable. Systematic Review Mon, 27 Apr 2026 00:00:00 GMT Mon, 27 Apr 2026 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002368 FDA 2025 Cancer Drug Approvals: targeted therapy dominates https://www.explorationpub.com/Journals/etat/Article/1002369 Not applicable. Commentary Mon, 27 Apr 2026 00:00:00 GMT Mon, 27 Apr 2026 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002369 The evolving landscape of first-line and subsequent therapies in EGFR-mutated NSCLC: efficacy, resistance, and tolerability https://www.explorationpub.com/Journals/etat/Article/1002370 Not applicable. Mini Review Tue, 28 Apr 2026 00:00:00 GMT Tue, 28 Apr 2026 00:00:00 GMT https://www.explorationpub.com/Journals/etat/Article/1002370